These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28748226)

  • 1. Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.
    Oxenkrug G; van der Hart M; Roeser J; Summergrad P
    Integr Clin Med; 2017; 1(1):. PubMed ID: 28748226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes.
    Fiedorowicz M; Choragiewicz T; Thaler S; Schuettauf F; Nowakowska D; Wojtunik K; Reibaldi M; Avitabile T; Kocki T; Turski WA; Kaminska A; Grieb P; Zrenner E; Rejdak R; Toro MD
    Front Physiol; 2019; 10():1254. PubMed ID: 31632294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Tryptophan - Kynurenine Metabolism Associated with Metabolic Syndrome is Different in Parkinson's and Alzheimer's Diseases.
    Oxenkrug G; van der Hart M; Roeser J; Summergrad P
    Endocrinol Diabetes Metab J; 2017 Nov; 1(4):. PubMed ID: 29292800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
    Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
    Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenic acid, an aryl hydrocarbon receptor ligand, is elevated in serum of Zucker fatty rats.
    Oxenkrug G; Cornicelli J; van der Hart M; Roeser J; Summergrad P
    Integr Mol Med; 2016; 3(4):761-763. PubMed ID: 27738521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid.
    Mori Y; Mouri A; Kunisawa K; Hirakawa M; Kubota H; Kosuge A; Niijima M; Hasegawa M; Kurahashi H; Murakami R; Hoshi M; Nakano T; Fujigaki S; Fujigaki H; Yamamoto Y; Nabeshima T; Saito K
    Behav Brain Res; 2021 May; 405():113191. PubMed ID: 33607168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
    Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
    Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
    Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A
    Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthranilic Acid: A Potential Biomarker and Treatment Target for Schizophrenia.
    Oxenkrug G; van der Hart M; Roeser J; Summergrad P
    Ann Psychiatry Ment Health; 2016; 4(2):. PubMed ID: 27042691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
    Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
    Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine pathway dynamics in patients with schizophrenia spectrum disorders across the disease trajectory.
    Kuuskmäe C; Philips MA; Kilk K; Haring L; Kangro R; Seppo I; Zilmer M; Vasar E
    Psychiatry Res; 2023 Oct; 328():115423. PubMed ID: 37639988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity.
    Morita N; Hoshi M; Hara T; Ninomiya S; Enoki T; Yoneda M; Tsurumi H; Saito K
    Oncol Lett; 2021 Nov; 22(5):790. PubMed ID: 34584567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
    Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
    Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
    Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
    Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.